CLINICAL EXPERIENCES OF TYPE 2 DIABETES (T2DM) PATIENTS INITIATING ORAL SEMAGLUTIDE

被引：0
|
作者：
Dunn, T. J. [1 ]
Swift, C. [1 ]
Guesnier, A. [1 ]
Noone, J. [1 ]
Willey, V [2 ]
机构：
[1] Novo Nordisk Inc, Plainsboro, NJ USA
[2] HealthCore Inc, Wilmington, DE USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO30
引用
收藏
页码：S309 / S309
页数：1
相关论文
共 50 条
  • [21] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [22] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [23] Presentation and course of type 2 diabetes (T2DM) in childhood
    Zdravkovic, V
    Daneman, D
    Hamilton, J
    DIABETES, 2003, 52 : A405 - A406
  • [24] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [25] Characteristics and Medication Adherence of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Linagliptin and Other Diabetes Medications (Noninsulin) in Routine Care
    Patorno, Elisabetta
    Gopalakrishnan, Chandrasekar
    Zorina, Olesya
    Schneeweiss, Sebastian
    Bartels, Dorothee
    Liu, Jun
    Seeger, John
    DIABETES, 2015, 64 : A443 - A443
  • [26] Empagliflozin improves blood pressure in patients with type 2 diabetes (T2DM) and hypertension
    Tikkanen, I.
    Narko, K.
    Zeller, C.
    Green, A.
    Salsali, A.
    Broedl, U. C.
    Woerle, H. J.
    DIABETOLOGIA, 2013, 56 : S377 - S377
  • [27] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [28] High Incidence of Elevated Lipase and Amylase in Type 2 Diabetes Patients (T2DM)
    Bastyr, E. J.
    Barkin, J.
    Botros, F. T.
    Shu, J.
    PANCREAS, 2009, 38 (08) : 984 - 984
  • [29] Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program
    Mahaffey, Kenneth W.
    Ianus, Juliana
    Damaraju, C. V.
    Neal, Bruce
    De Zeeuw, Dick
    Fulcher, Greg
    Pfeifer, Michael
    Matthews, David R.
    DIABETES, 2019, 68
  • [30] Effect of empagliflozin (EMPA) on bone fractures in patients with type 2 diabetes (T2DM)
    Kohler, S.
    Kaspers, S.
    Salsali, A.
    Zeller, C.
    Woerle, H. -J.
    DIABETOLOGIA, 2016, 59 : S26 - S26
12345